Fundraising FoxYzybio
Wuhan, CN · 1 known investors
Find your way into Yzybio
Sign up to see every warm intro you have to Yzybio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Yzybio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Wuhan YZY Biopharma is a biotechnology company developing bispecific antibody (BsAb) therapies to treat cancer, cancer-related complications, and age-related ophthalmic diseases. It also develops preventive and therapeutic vaccines, including Y2019, a recombinant SARS-CoV-2 subunit protein vaccine developed with the Wuhan Institute of Virology.
Investors · 1
Frequently asked questions
- What does Yzybio do?
- Wuhan YZY Biopharma is a biotechnology company developing bispecific antibody (BsAb) therapies to treat cancer, cancer-related complications, and age-related ophthalmic diseases. It also develops preventive and therapeutic vaccines, including Y2019, a recombinant SARS-CoV-2 subunit protein vaccine developed with the Wuhan Institute of Virology.
- Who are Yzybio's investors?
- Yzybio's investors include Pan-Lin Capital.
- Where is Yzybio headquartered?
- Yzybio is headquartered in Wuhan, CN.